Depression

Americans with anxiety, depression, and PTSD would be willing to try ketamine, psilocybin, and MDMA if they worked better than traditional medications, a Harris Poll finds.

"COVID-somnia," defined as a group of chronic sleep disturbances, has made adequate rest elusive for millions, including health care first responders.

Click through a short summary of the provisions of the Dr Lorna Breen Health Care Provider Protection Act.

The first-of-its-kind legislation would authorize $35 million for programs aimed at practitioner mental health education and campaigns to support seeking help.

Older adults who report being "highly lonely" are up to 2.5 times more likely to use opioid analgesics, sedatives, and anxiolytics.

Compared to psychiatrists and subspecialists, the proportion of visits to primary care was higher for patients with depression or anxiety and any mental illness in a new cross-sectional study.

Antidepressant therapy, used as prescribed, reduced risk for advanced complications of diabetes and death among more than 36 000 patients with comorbid diabetes and depression.

The COVID-19 pandemic has sorely challenged the emotional well being of all healthcare providers. Here, a look back is followed by a guide to moving forward.

What does the latest research say about the association between mental health and cardiovascular disease? Scroll through our quick slideshow for an overview.

Director of the National Institute on Alcohol Abuse and Alcoholism George F Koob, PhD, talked with Patient Care Online about dangerous alcohol consumption linked to pandemic-related stress.

Developed by researchers from the University of Pennsylvania Health System, the model uses a referral management system to support primary care patients with mental health needs.

Healthcare providers are advised to weigh carefully the risks vs benefits of continuing lamotrigine therapy and not to substitute with another drug from the class.

Stroke patients are nearly 50% more likely vs heart attack patients to develop depression, according to new research being presented at the upcoming International Stroke Conference.

Irregular sleeping patterns can increase risk of depression and lower daily mood over the long term, according to a new study of first-year medical students.

Are you caught up on the latest guidance for the nonpharmacologic and pharmacologic treatment of major depressive disorder? Find out with this quick quiz.

Prevalence of depression in the US has increased nearly 3-fold since before COVID-19. Here, a primer on the best assessment tools for depression diagnosis in primary care.

Ketamine used in patients with treatment-resistant depression operates via serotonin 1B receptors by way of a previously unknown mechanism of action, according to a new study from Sweden.

Analysis of EEG data from patients with major depressive disorder predicted response to SSRI treatment with accuracy of nearly 80%, according to a new study.

Highlights from a recent evidence-based review offer guidance on feasible depression treatments in primary care.

Highlights of an evidence-based review offer practical guidance for effective depression screening and assessment strategies for primary care physicians.

A new study being presented next week at AHA's 2019 Scientific Sessions found a strong link between depression and non-fatal heart disease. 

A new study suggests that deep brain stimulation may be a safe and effective treatment option for patients with treatment-resistant depression. 

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

This month, our app reviewer selected the top 5 depression apps that you and your patients can use. Which ones made the cut?

Five tips for PCPs on managing treatment-resistant depression were offered at the ACP Internal Medicine Meeting 2018 today. Patient Care offers a summary.